AstraZeneca (AZN) net assets (shareholders' equity)

Net assets · fiscal 2025
$48.67B

AstraZeneca (AZN) had net assets of $48.67B at the end of fiscal 2025 (December 31, 2025). That is 19.3% higher than the $40.79B of fiscal 2024. Figures as of 18 Nov 2026, 21:06 UTC, from Yahoo Finance.

Key facts

Net assets, fiscal 2025
$48.67B
Change on fiscal 2024
+19.3%
Highest on record
$48.67Bfiscal 2025
Lowest on record
$37.04Bfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

AstraZeneca net assets (shareholders' equity), in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $48.67B in fiscal 2025 and the lowest $37.04B in fiscal 2022.

History · 4 fiscal years

Net assets by fiscal year

AstraZeneca net assets (shareholders' equity), year by year

AstraZeneca (AZN) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$48.67B 19.3% up
2024$40.79B 4.2% up
2023$39.14B 5.7% up
2022$37.04B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of AstraZeneca and comparable companies
CompanyNet assetsFiscal year
Merck & Co MRK$52.61B2025
UnitedHealth Group UNH$94.11B2025
Novartis NVS$46.13B2025
AstraZeneca AZN$48.67B2025
Thermo Fisher Scientific TMO$53.41B2025
Amgen AMGN$8.66B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on AZN

AstraZeneca, figure by figure

AstraZeneca (AZN) overview: price, valuation and scorecardAll health care companies by market value

AstraZeneca net assets (shareholders' equity): questions and answers

What are AstraZeneca's net assets?

AstraZeneca (AZN) had net assets of $48.67B at the end of fiscal 2025 (December 31, 2025). That is 19.3% higher than the $40.79B of fiscal 2024.

What are the highest and lowest net assets figures on record for AstraZeneca?

Across the 4 fiscal years on record (2022–2025), the highest was $48.67B in fiscal 2025 and the lowest $37.04B in fiscal 2022.

How is AstraZeneca's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For AstraZeneca it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “AstraZeneca (AZN) net assets (shareholders' equity)”, data as of 18 November 2026. https://funkfolio.com/stock/AZN/net-assets

Underlying data: Yahoo Finance.